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Accepted 13 June 2013AbstractObjective: To determine whether advanced male age influences the outcome of intracytoplasmic sperm injection (ICSI) following the cryo-
preservation of spermatozoa obtained through testicular sperm extraction (TESE).
Materials and Methods: Data were collected from infertile couples suffering from azoospermia who underwent TESE and ICSI from January
1998 to August 2010. There were 212 ICSI cycles using extracted testicular sperm after cryopreservation in this retrospective clinical analysis.
The participating men all underwent testicular biopsy and subsequent tissue cryopreservation in a single academic tertiary care medical center.
Those cryopreserved sperm were used during consecutive intracytoplasmic sperm injection treatment cycles. Female partners underwent
individualized controlled ovarian hyperstimulation programs.
Results: A total of 184 ICSI cycles were divided into the following two evaluation designs: (1) total cycles irrespective maternal age; (2) ICSI
cycles with maternal age <34 years. Male partners were stratified into age categories at 5-year intervals (31e35 years, 36e40 years, and 41e51
years) in these two designs. In the first design, most outcomes of assisted reproductive techniques were similar during the three groups, but the
maternal age is much lower in the first group, and the mean number of retried oocytes and estradiol level on the day of human chorionic
gonadotropin injection was significantly higher in the first group. In the second design, the outcome of intracytoplasmic sperm injection and
clinical factors including the estradiol level on the day of human chorionic gonadotropin injection, the number of retrieved oocytes, the rate of
cleaved oocytes, the number of transferred embryos, the numbers of transferred good embryos, the clinical pregnancy rate per transfer cycle and
the implantation rate were similar among the three groups of women aged <34 years after adjusting for female age.
Conclusions: There is insufficient evidence to demonstrate an unfavorable effect of advanced paternal age on the fertility outcome for TESE-
ICSI. The thawed testicular spermatozoa from males aged 40 years did not have an adverse impact on ICSI outcomes.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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http://dx.doi.org/10.1016/j.tjog.2013.06.001including the etiology of infertility, patient age, the type of
ovarian stimulation, and the level of follicular phase estradiol
(E2). The subsequent number and quality of oocytes and the
number of embryos transferred are affected by the different
regimens of ovarian stimulation [1]. The impact of these
factors on the outcome of intracytoplasmic sperm injection
(ICSI) following testicular sperm extraction (TESE) has also
been examined, including a comparison of fresh and freeze-
thawed testicular sperm as well as the length ofcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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female age on pregnancy outcomes are well known [5e7].
Female fertility decreases after age 35 years and declines
sharply after age 39 years [8,9], and advanced female age has
been associated with poor ART results [10e13].
Comparedwithmaternal age, few studies have focused on the
effect of paternal age on ARToutcomes, and some of the results
are conflicting [9]. The review by Kidd et al [14] evaluating the
effects of male age on fertility and semen quality concluded that
advanced male partner age is associated with lower semen
volume, sperm motility, and morphology, but no change in
sperm concentration was noted. This review found that
advanced male age negatively affected fertility, particularly in
men aged>50 years. Recently, some studies have also evaluated
the effect of paternal age on semen characteristics and have
found similar declines in total sperm count, total motile sperm
count, and total semen volume [9,15,16].
According to a review from 2011 [9], there was no sig-
nificant relationship between advanced paternal age and ICSI
outcomes among ejaculated sperm, but there were some con-
flicting results, such as the decreased blastocyst formation in
men >50 years [13]. However, the effects of male age on the
spermatozoa obtained from cryopreservation of TESE tissue
remain unknown. The aim of this study was to investigate the
impact of advanced male age on outcomes following cryo-
preservation and TESE.
Materials and methodsStudy populationThis was a 14-year study that began in 1997. All partici-
pating patients underwent a complete physical examination of
their genitalia to evaluate the anatomy of the seminal vesicles,
prostate, distal vasa deferentia, and ejaculatory ducts by an
experienced urologist in our hospital. Male patients diagnosed
as having azoospermia underwent TESE with routine cryo-
preservation at our hospital. Thawed testicular spermatozoa
were subsequently used for a total of 212 ICSI cycles until
August 2010. After excluding men <31 years, 184 ICSI cycles
were included in our analysis.Testicular tissue extraction, preparation of testicular
sperm, and cryopreservation of testicular spermatozoaPatients exhibiting azoospermia agreed to undergo TESE
subsequent to their routine work-up. A formal scrotal explo-
ration was performed prior to the surgical testicular-tissue
extraction procedure. The cryopreservation of testicular sper-
matozoa was as described previously [3,17]. Briefly, the
effluent that contained the sperm was put in culture medium
(Medicult, Copenhagen, Denmark) and centrifuged for 20
minutes at 300  g, after which it was washed twice. Test yolk
buffer containing glycerol was added to the sperm suspension,
and 500-mL aliquots of the mix were transferred to sterile
polypropylene tubes. Then, 10 mL of the suspension was
delaminated to examine the presence of fully formedspermatozoa by phase-contrast microscopy. The tube was put in
a 37 C incubator for 15 minutes and shifted to a 4 C refrig-
erator for another 15 minutes. This was followed by incubation
at 20 C for another 15 minutes. During the last step, the tubes
were left ate60 C for 5 minutes. Finally, the tubes were stored
in liquid nitrogen.Ovarian stimulationOvarian stimulation and oocyte retrieval were performed as
described in previous studies [3,17]. Briefly, all patients un-
derwent a long stimulation protocol using a gonadotropin-
releasing hormone (GnRH) agonist (Luproid acetate; Takeda,
Tokyo, Japan) therapy followed by the administration of a
urinary follicle-stimulating hormone (FSH, Metrodin; Serono
Laboratories Inc., Randolph, MA, USA) or administration of
recombinant follicle-stimulating hormone (r-FSH; Gona-F
Serono Laboratories Inc., Randolph, MA, USA) and trans-
vaginal oocyte retrieval. Human chorionic gonadotropin (hCG;
Pregnyl, N.V. Organon/Oss, The Netherlands) was adminis-
tered (10,000 IU) intramuscularly when ultrasound revealed
at least one follicle featuring a mean diameter of 17 mm
and/or when serum estradiol levels exceeded 400 pg/mL.
Oocytes were retrieved by transvaginal aspiration under
ultrasound guidance 35e37 hours subsequent to the injection
of hCG.
Following oocyte retrieval, the oocytes were exposed to
type VIII hyaluronidase (80 IU/mL; Sigma Chemical Co., St
Louis, MO, USA) for a period of 5e6 seconds. The oocytes
were then separated from the surrounding cumulus cells by
aspiration through a series of pipettes with decreasing inner
diameters (commencing at 220 mm, and progressing through
200 mm, 180 mm, and 160 mm), in 100-mL droplets of human
tubal fluid (HTF) medium.ICSI procedureThe ICSI procedures were followed by the previous studies
[3]. Briefly, a two-layer gradient was set for purifying the
thawed specimens. Most of the spermatozoa that were selected
under these two criteria had at least occasional tail twitching and
normal morphology. The following modification was adopted
for the preparation of sperm droplets: 1 mL of prepared sperm
suspension was added to 2e4 mL of M2 medium (Medicult,
Copenhagen, Demark) containing no polyvinylpyrrolidone.
Fertilization was confirmed 16e18 hours after insemination
andwas defined by the presence of two distinct pronuclei. If only
one pronucleus was observed, a second evaluation was per-
formed after 4 hours. Embryonic division andmorphology were
evaluated every 24 hours and classified according to the
morphological grading system. Daily intravaginal luteal phase
supplementation of 800 mg of micronized progesterone was
started on the day of oocyte retrieval, and 5000 IU HCG was
administered on Day 6 after oocyte recovery in all patients.
Clinical pregnancy was defined as the identification of a gesta-
tional sac at 7 weeks of gestation by transvaginal sonography.
Micronized progesterone was administered to prospective
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defined the implantation rate as the number of gestational sacs
divided by the total number of transferred embryos.Outcome measuresThe primary outcome measure of this study was the live
birth rate. Secondary outcome measures included the clinical
pregnancy rate, the implantation rate, the fertilization rate,
embryo development, and the mean number of transferred
good embryos. A good embryo was defined as a Grade 1 or
Grade 2 embryo. Embryos were graded by the number and
symmetry of distinct blastomeres and by the percentage of
total embryo volume consisting of cellular fragments on the
day of embryo transfer.Statistical analysisResults are expressed as the mean  standard error of the
mean for numeric variables. Categorical variables are
expressed as proportions (%). The statistical evaluation was
performed using one way ANOVA, Fisher’s test, and a c2 test.
A p value <0.05 was considered to be statistically significant.
Results
A total of 212 ICSI treatment cycles were performed during
the study period. After excluding men <31 years, male part-
ners were stratified into age categories at 5-year intervalsTable 1
Influence of male age on intracytoplasmic sperm injection (ICSI) outcome with th
31e35
No. of ICSI cycle azoospermia type
(nonobstructive:obstructive azoospermia)
84 (51/33)
Female age (y) 31.0  0.4
Female factor with endometriosis or ovulation 3 (3.5)
Gonadotropin dose (Amp/75 IU) 30.9  1.2
Mean no. of retrieved oocytes 8.4  0.5
Total no. of injected oocytes 612
Total no. of fertilized oocytes 545
Mean rate of fertilization 88.3  1.9
Total no. of cleaved oocytes 528
Mean rate of cleavage 96.9  1.7
No. of blastomeres on Day-2 embryos
 3 139 (26.3)
 4 389 (73.7)
Embryo quality on Day-2 embryos
Good 415 (78.6)
Poor 113 (21.4)
Mean no. of good embryo per transfer 2.9  0.2
Estradiol level on hCG day 2220.3  160.
Clinical pregnancy rate per transfer 38/84 (45.2)
Implantation rate 54/251 (21.5)
Live birth rate 35/84 (41.7)
Abortion rate 7/84 (8.3)
Data are presented as mean  standard error of the mean or n (%).
a The results are significantly different ( p < 0.05) compared with the result in t
compared with the result in the age >35e40 years group.(31e35 years, 36e40 years, and >40e51 years). In Table 1,
the mean age of the females in the first group was less than the
other two groups due to the lack of age adjustment. This group
also experienced less ovarian stimulation and had a greater
number of oocytes and a higher estradiol level. The general
embryo quality was lower in the first group, but the better
quality of the transferred embryo was noted after selection.
The clinical pregnancy rate, implantation rate, live birth rate,
and abortion rate were similar across all three groups. The
distribution of oligozoospermic and nonoligozoospermic
azoospermia patients was similar in Table 1. In order to
exclude the influence of maternal age to clearly elucidate the
effect of paternal age, we excluded couples with a maternal
age >34 years to control for this factor. In Table 2, female age
was similar after matching for age. The distribution of oligo-
zoospermic and nonoligozoospermic azoospermia patients
was also similar. The dose of ovarian stimulation was also not
significantly different. Similar numbers of retrieved oocytes
were also noted, which indicated a similar ovarian reserve
among the three groups. There was no statistically significant
difference in the fertilization rates of the retrieved oocyte
between groups. Additionally, the embryo quality was similar
among groups, suggesting that the sperm and oocytes used in
the procedure were of similar quality. The percentage of top-
quality embryos used in these groups was similar. The im-
plantation rate was not significantly different among the three
groups. Additionally, the live birth rate did not decrease
among those with advanced paternal age. These results are
related to the good control of female factors.awed testicular sperm in all women.
Male age interval (y)
>35e40 >40
56 (33/23) 44 (23/21)
33.4  0.6a 34.2  0.9b
6 (10) 2 (4.5)
33.6  2.2 33.7  2.0
6.1  0.5a 5.8  0.4b
286 198
252 182
84.4  3.7 92.2  1.9
245 175
87.6  4.1a 92.4  3.5
59 (24.1) 43 (24.6)
186 (75.9) 132 (75.4)
189 (77.1)a 141 (80.6)a
56 (22.9) 34 (19.4)
2.5  0.3 2.2  0.2
5 1646.9  172.6a 1279.6  118.2a
23/56 (41.1) 17/44 (38.6)
21/135 (15.6) 27/110 (24.6)
19/56 (33.9) 14/44 (31.8)
4/56 (7.1) 3/44 (6.8)
he age 31e35 years group; b The result are significantly different ( p < 0.05)
Table 2
Influence of male age on intracytoplasmic sperm injection (ICSI) outcome with thawed testicular sperm in the women (aged 34 years).
Male age interval (y)
31e35 >35e40 >40
No. of ICSI cycles azoospermia type
(nonobstructive:obstructive azoospermia)
69 (45/24) 30 (20/10) 15 (10/5)
Female age (y) 30.4  0.3 30.2  0.6 29.8  1.0
Female factor with endometriosis or ovulation 2 (2.8) 6 (20)a 0 (0)
Gonadotropin dose (Amp/75 IU) 31.4  1.3 31.9  2.9 27.3  2.3
Mean no. of retrieved oocytes 8.5  0.6 6.9  0.7 7.3  0.8
Total no. of injected oocytes 519 170 94
Mean no. of injected oocytes 7.4  0.5 5.7  0.7 5.7  0.7
Total no. of fertilized oocytes 461 (88.8) 150 (88.2) 88 (90.5)
Mean rate of fertilization 88.6  2.1 81.3  2.9 93.1  3.6
Total no. of cleaved oocytes 444 (96.3) 148 (98.7) 85 (94.7)
Mean rate. of cleavage 97.6  1.5 86.0  1.2a 97.8  1.5
No. of blastomeres on Day-2 embryos
3 109 (24.6) 28 (18.9) 21 (27.8)
4 335 (75.4) 120 (81.1) 64 (72.2)
Embryo quality on Day-2 embryos
Good 344 (77.5) 113 (78.4) 64 (74.1)
Poor 100 (22.5) 35 (21.6) 21 (25.9)
Mean no. of good embryos per transfer 2.8  0.2 2.4  0.3 2.9  0.3
Estradiol level on hCG day 2255.8  183.7 1521.3  182.7 1539.9  223.9
Clinical pregnancy rate per transfer 32/69 (46.4) 13/30 (43.3) 7/15 (46.7)
Implantation rate 49/215 (22.8) 18/75 (24.0) 12/46 (34.4)
Live birth rate 23/69 (33.3) 11/30 (36.7) 6/15 (40)
Abortion rate 7/69 (10.1) 3/30 (10) 1/15 (6)
Data are presented as mean  standard error of the mean or n (%).
a The results are significantly different ( p < 0.05) compared with the result in the age 31e35 years group.
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Among most previous studies, the main impact of male
aging on natural pregnancy outcome was decreased sperm
parameters [14,18]. It is unknown whether IVF outcomes are
affected by sperm from aging males. One paper mentioned the
poor conception rate of IVF with a paternal age 40 years
[19]. A recent review by Dain et al [9] suggests a significant
decrease in blastocyst embryo formation associated with
increased paternal age. Decreased semen volume and motility
with increasing age were also mentioned in a cohort study, but
they did not find an association between paternal age and the
likelihood of live birth [7]. Based on those reviews, [7,9], there
is no obvious evidence demonstrating a negative effect of
advanced paternal age on IVF outcomes.
Although the sperm are selected via microscopy for ICSI
procedures, it is unknown whether ICSI outcomes are affected
by sperm from aging males. The influence of advanced male
age on ICSI outcomes suffers from insufficient and conflicting
data and not yet well established [16,19]. In our TESE group,
the fertility rate in the aging groups (>40 years) was adequate.
However, as mentioned above, some studies have suggested a
negative trend in fertility with advanced male age [14,19]. A
similar trend was noted when we separated patients into
subgroups of paternal age (31e35 years, 36e40 years, 40e45
years, and >45 years). We found very large declines in the
clinical pregnancy rate, implantation rate, and live birth rate
with a paternal age >45 years. However, due to the limited
number of cases, additional patients are required prior to whena conclusion regarding the influence of advanced male age
(>40 years) can be drawn.
As many studies have suggested, advanced male age is
related to the risk of chromosomal abnormalities in sperma-
tozoa and might increase the spontaneous abortion rate
[20,21]. However, the abortion rate in our study was similar
between groups. Additionally, clinical data were similar and
satisfactory between the groups in our study. Therefore, the
excellent ART data in our study lead us to ask how the TESE-
ICSI procedures can compensate for the negative effects of
advanced male age. According to our review, several studies
have suggested that DNA fragmentation is increased by the
freezeethaw procedure [22e25]. Additionally, our team
demonstrated that the post-thaw vitality was significantly
different from the vitality of fresh sperm [26]. According to
those findings, we have two hypotheses. First, an age-
dependent impact may play an important role in epididymal
sperm maturation by disturbing sperm mitochondrial function
[18,27]. We suggest that TESE is a good way to avoid the
influence of poor environment of the seminiferous tubules (in
the epididymis and the ejaculatory duct) that ejaculated sperm
have to pass through in older males.
Second, we hypothesize that our cryoethaw TESE pro-
cedures result in excellent selection in poor quality spermatozoa
related with advanced paternal age. We suggested that TESE
sperm with chromosomal abnormalities are affected more dur-
ing the cryoethaw TESE procedure. So the poor quality sper-
matozoa related with advanced paternal age are less likely to
survive following the procedure. Therefore, we hypothesize that
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quality was bypassed after the selection system.
There are still some limitations that need to be acknowl-
edged and addressed regarding the present study. First, the
topic of this study can be only analyzed retrospectively. The
impact of more advanced age (>40 years) needs to be estab-
lished with a larger sample. Although many studies have
suggested that advanced male age has negative impacts on the
outcomes of natural pregnancy and artificial pregnancy
following ART, it appears that these effects can be overcome
by the use of the cryoethaw TESE and ICSI procedures.
Thawed testicular spermatozoa from men aged 40 years did
not have an adverse impact on ICSI outcomes.
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